Key findings for this claim are the identification of significant associations between this marker and poor prognosis in multivariable analyses of two patient series, one consisting of 108 cases analyzed as whole sections and the other consisting of 267 TMA-based cases of ER + breast cancer. This evidence concerns the gene ESR1 and breast cancer.